EUnetHTA JA Methodology Archive (2010 – 2012)

EUnetHTA JA Methodology Archive (2010 – 2012)

Methodological guidelines for rapid relative effectiveness assessment (REA) of Pharmaceuticals

 

  1. Clinical endpoints
  2. Composite endpoints
  3. Surrogate endpoints
  4. Safety
  5. Health-related quality of life
  6. Criteria for the choice of the most appropriate comparator(s)
  7. Direct and indirect comparison
  8. Internal validity
  9. Applicability of evidence in the context of a relative effectiveness assessment

 

Please note that the updated versions of these Guidelines can be found under JA2 Guidelines here.